• head_banner_01

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We emphasize development and introduce new products into the market every year for Calais, Ethylamino Ethanol, Cas 2309-49-1, To learn more about what we can easily do in your case, make contact with us at any time. We glance forward to developing superior and long-term organization interactions along with you.
Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

go on to boost, to be certain item quality in line with market and buyer standard demands. Our firm has a excellent assurance procedure happen to be established for Good Wholesale Vendors Branched Chain Amino Acids - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Mauritius, Mumbai, Madagascar, We have top engineers in these industries and an efficient team in the research. What is more, now we have our own archives mouths and markets in China at low cost. Therefore, we can meet different inquiries from different clients. Remember to find our website to check more information from our merchandise.
  • We have been engaged in this industry for many years, we appreciate the work attitude and production capacity of the company, this is a reputable and professional manufacturer.
    5 Stars By Ivy from Turkey - 2018.11.22 12:28
    The supplier cooperation attitude is very good, encountered various problems, always willing to cooperate with us, to us as the real God.
    5 Stars By Julia from Slovak Republic - 2018.07.26 16:51
    Write your message here and send it to us